+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Abbott Diagnostics - Product Pipeline Analysis, 2022 Update

  • PDF Icon

    Company Profile

  • 335 Pages
  • February 2023
  • GlobalData
  • ID: 5740133
Description Jump to:
Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics. Abbott products portfolio include laboratory systems for automation; molecular diagnostic systems, and point of care systems for blood analysis. The company products find application in therapeutic drug monitoring, measurement of antibodies and antigens, and screening and diagnosis of cancer. Abbott serves blood banks, hospitals, commercial laboratories, government agencies, patient care testing sites, and plasma protein therapeutic companies. The company markets its products through Abbott-owned distribution centers, public warehouses and third-party distributors. Abbott is headquartered in Lake Forest, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abbott Diagnostics
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Abbott Diagnostics Company Overview
  • Abbott Diagnostics Company Snapshot
  • Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
  • Abbott Diagnostics - Pipeline Analysis Overview
  • Abbott Diagnostics - Key Facts
  • Abbott Diagnostics - Major Products and Services
  • Abbott Diagnostics Pipeline Products by Development Stage
  • Abbott Diagnostics Ongoing Clinical Trials by Trial Status
  • Abbott Diagnostics Pipeline Products Overview
  • 13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • ACTN4 Companion Diagnostic Assay - Lung Cancer
  • AKT Companion Diagnostic Assay - Breast Cancer
  • AKT Companion Diagnostic Assay - Colorectal Cancer
  • AKT Companion Diagnostic Assay - Renal Cancer
  • Alinity i AdviseDx SARS-CoV-2 IgM Assay
  • Alinity i Assay - TBI
  • ALK Companion Diagnostic Assay - Colorectal Cancer
  • ALK Companion Diagnostic Assay - Lung Cancer
  • AR Companion Diagnostic Assay - Breast Cancer
  • AR Companion Diagnostic Assay - Prostate Cancer
  • Architect AdviseDx SARS-Cov-2 IgM Assay
  • Architect Assay - TBI
  • ARCHITECT c16000 System - Ca 72.2 Assay
  • ARCHITECT c4000 System - Ca 72.2 Assay
  • ARCHITECT c4000 System - High Sensitive Troponin-I Assay
  • ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay
  • ARCHITECT c4000 System - TRAb Assay
  • ARCHITECT c8000 Integrated System - Galectin-3 Assay
  • ARCHITECT c8000 System - Ca 72.2 Assay
  • ARCHITECT c8000 System - High Sensitive Troponin-I Assay
  • ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay
  • ARCHITECT c8000 System - TRAb Assay
  • ARCHITECT ci16200 Integrated System - Ca 72.2 Assay
  • ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay
  • ARCHITECT ci16200 Integrated System - NT Pro BNP Assay
  • ARCHITECT ci16200 Integrated System - TRAb Assay
  • ARCHITECT ci4100 Integrated System - NT Pro BNP Assay
  • ARCHITECT ci4100 Integrated System - TRAb Assay
  • ARCHITECT ci8200 Integrated System - Ca 72.2 Assay
  • ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay
  • ARCHITECT ci8200 Integrated System - TRAb Assay
  • ARCHITECT i1000SR - NT Pro BNP Assay
  • ARCHITECT i2000SR Integrated System - NT Pro BNP Assay
  • ATM q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • AURKA Companion Diagnostic Assay - Bladder Cancer
  • AURKA Companion Diagnostic Assay - Prostate Cancer
  • AXL Companion Diagnostic Assay - Lung Cancer
  • BCL2 Companion Diagnostic Assay - Leukemia
  • BCL2 Companion Diagnostic Assay - Lymphoma
  • BCL6 Companion Diagnostic Assay - Lymphoma
  • BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia
  • Biomarker-Based Molecular Diagnostic Test - Prostate Cancer
  • BRAF Companion Diagnostic Assay - Colorectal Cancer
  • BRAF Companion Diagnostic Assay - Gastric Cancer
  • BRAF Companion Diagnostic Assay - Glioblastoma
  • BRAF Companion Diagnostic Assay - Lung Cancer
  • BRAF Companion Diagnostic Assay - Melanoma
  • BRAF Companion Diagnostic Assay - Ovarian Cancer
  • BRCA1 Companion Diagnostic Assay - Ovarian Cancer
  • BRCA2 Companion Diagnostic Assay - Ovarian Cancer
  • c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma
  • CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia
  • CCND1 Companion Diagnostic Assay - Breast Cancer
  • CCND1 Companion Diagnostic Assay - Lymphoma
  • CCND1 Companion Diagnostic Assay - Melanoma
  • CDK6 Companion Diagnostic Assay - Leukemia
  • CDKN2C Companion Diagnostic Assay - Multiple Myeloma
  • CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome
  • CEP 9 Companion Diagnostic Assay - Multiple Myeloma
  • Chromosome Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • Chromosome Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • Chromosome Companion Diagnostic Assay - Cervical Cancer
  • Chromosome Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • Chromosome X Companion Diagnostic Assay - Cervical Cancer
  • cKIT Companion Diagnostic Assay - Gastric Cancer
  • cKIT Companion Diagnostic Assay - Melanoma
  • CKS1B Companion Diagnostic Assay - Breast Cancer
  • CKS1B Companion Diagnostic Assay - Multiple Myeloma
  • CLL FISH Probe Kit - Ibrutinib
  • cMET Companion Diagnostic Assay - Brain Cancer
  • cMET Companion Diagnostic Assay - Breast Cancer
  • cMET Companion Diagnostic Assay - Kidney Cancer
  • cMET Companion Diagnostic Assay - Lung Cancer
  • Companion Diagnostic Test - B-cell Lymphoma
  • Companion Diagnostic Test - Cancer
  • COT Companion Diagnostic Assay - Melanoma
  • CRAF Companion Diagnostic Assay - Melanoma
  • CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • D5S23 Companion Diagnostic Assay - Cervical Cancer
  • D5S23/D5S721 CEP 9 Companion Diagnostic Assay - Multiple Myeloma
  • D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • D5S721 Companion Diagnostic Assay - Cervical Cancer
  • D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome
  • D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • DCC Companion Diagnostic Assay - Colorectal Cancer
  • DDR2 Companion Diagnostic Assay - Lung Cancer
  • DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • del(17p) Companion Diagnostic Assay - Multiple Myeloma
  • del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • DOT1L Companion Diagnostic Test
  • DPP4 Based Companion Diagnostic Assay - Asthma
  • E2A/PBX1 (TCF/PBX1) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • EGFR Companion Diagnostic Assay - Brain Cancer
  • EGFR Companion Diagnostic Assay - Glioblastoma
  • EGFR Companion Diagnostic Assay - Lung Cancer
  • EGFRvIII Companion Diagnostic Assay - Glioblastoma
  • EGFRvIII Companion Diagnostic Assay - Lung Cancer
  • EGR1/D5S23 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • EGR1/D5S23 Companion Diagnostic Assay - Myelodysplastic Syndrome
  • EML4 Companion Diagnostic Assay - Lung Cancer
  • ERBB3 Companion Diagnostic Assay - Bladder Cancer
  • ERG Companion Diagnostic Assay - Prostate Cancer
  • ETV Companion Diagnostic Assay - Sarcoma
  • ETV1 Companion Diagnostic Assay - Prostate Cancer
  • FGFR1 Companion Diagnostic Assay - Breast Cancer
  • FGFR1 Companion Diagnostic Assay - Lung Cancer
  • FGFR2 Companion Diagnostic Assay - Breast Cancer
  • FGFR2 Companion Diagnostic Assay - Gastric Cancer
  • FGFR2 Companion Diagnostic Assay - Lung Cancer
  • FGFR3 Companion Diagnostic Assay - Bladder Cancer
  • FGFR3-TACC3 Companion Diagnostic Assay - Bladder Cancer
  • FGFR3-TACC3 Companion Diagnostic Assay - Lung Cancer
  • GNA11 Companion Diagnostic Assay - Melanoma
  • GNAQ Companion Diagnostic Assay - Melanoma
  • H3F3A Companion Diagnostic Assay - Glioblastoma
  • HER2 Companion Diagnostic Assay - Bladder Cancer
  • HER2 Companion Diagnostic Assay - Breast Cancer
  • HER2 Companion Diagnostic Assay - Gastric Cancer
  • HER2 Companion Diagnostic Assay - Lung Cancer
  • HER3 Companion Diagnostic Assay - Lung Cancer
  • Heregulin Companion Diagnostic Assay - Lung Cancer
  • HIF-1alpha Companion Diagnostic Assay - Renal Cancer
  • HOX11L2/TLX3 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • Hyperdiploidy Companion Diagnostic Assay - Multiple Myeloma
  • i(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • iAMP21 Companion Diagnostic Assay - Acute Lymphoblastic Leukamia
  • IDH1 Companion Diagnostic Assay - Biliary Cancer
  • IDH1 Companion Diagnostic Assay - Glioblastoma
  • IDH1 Companion Diagnostic Assay - Sarcoma
  • IDH2 Companion Diagnostic Assay - Glioblastoma
  • IDH2 Companion Diagnostic Assay - Sarcoma
  • idic(X)(q13) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • IGF1R Companion Diagnostic Assay - Breast Cancer
  • IGF1R Companion Diagnostic Assay - Colorectal Cancer
  • IGF1R Companion Diagnostic Assay - Lung Cancer
  • IGF1R Companion Diagnostic Assay - Melanoma
  • IGF1R Companion Diagnostic Assay - Multiple Myeloma
  • IGF1R Companion Diagnostic Assay - Prostate Cancer
  • IGFR-1 Companion Diagnostic Assay - Breast Cancer
  • IGFR-1 Companion Diagnostic Assay - Prostate Cancer
  • IGFR1 Companion Diagnostic Assay - Solid Tumor
  • IGH/CCND3 Companion Diagnostic Assay - Multiple Myeloma
  • IGH/MAFB Companion Diagnostic Assay - Multiple Myeloma
  • IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • inv(17q) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • inv(3) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • inv(3)(3q21q26.2) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • JAK2 Companion Diagnostic Assay - Breast Cancer
  • KEAP1 Companion Diagnostic Assay - Lung Cancer
  • KIF5B Companion Diagnostic Assay - Lung Cancer
  • KIT Companion Diagnostic Assay - Glioblastoma
  • KRAS Companion Diagnostic Assay - Colorectal Cancer
  • KRAS Companion Diagnostic Assay - Lung Cancer
  • KRAS Companion Diagnostic Assay - Melanoma
  • KRAS Companion Diagnostic Assay - Ovarian Cancer
  • KRAS Companion Diagnostic Assay - Solid Tumors
  • LKB1 Companion Diagnostic Assay - Lung Cancer
  • MAGEA3 Companion Diagnostic Assay - Melanoma
  • MAGEA3 Companion Diagnostic Assay - NSCLC
  • MAP3K1 Companion Diagnostic Assay - Breast Cancer
  • MCL1 Companion Diagnostic Assay - Biliary Cancer
  • MCL1 Companion Diagnostic Assay - Leukemia
  • MDM2/CEP12 Companion Diagnostic Assay - Sarcomas
  • MEK Companion Diagnostic Assay - Melanoma
  • MEK1 Companion Diagnostic Assay - Lung Cancer
  • MET Companion Diagnostic Assay - Colorectal Cancer
  • MET Companion Diagnostic Assay - Gastric Cancer
  • MET Companion Diagnostic Assay - Lung Cancer
  • MET Companion Diagnostic Assay - Ovarian Cancer
  • Methotrexate Chemiluminescent Assay
  • MGMT Companion Diagnostic Assay - Glioblastoma
  • MLL Companion Diagnostic Assay - Leukemia
  • MUC1 Companion Diagnostic Assay - Ovarian Cancer
  • MYB Companion Diagnostic Assay - Melanoma
  • MYC Companion Diagnostic Assay - Multiple Myeloma
  • MYC Companion Diagnostic Assay - Prostate Cancer
  • MYC t(8;14) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • MYCN Companion Diagnostic Assay - Prostate Cancer
  • MYD88 Companion Diagnostic Assay - Lymphoma
  • MYF11/CBFB inv (16)/t(16;16) Companion Diagnostic Assay - Acute Myeloid Leukemia
  • MYST3/CREBBP Companion Diagnostic Assay - Acute Myeloid Leukemia
  • Neuron-Specific Enolase (NSE) Assay
  • Next Generation Blood Screening System
  • NF1 Companion Diagnostic Assay - Lung Cancer
  • NF1 Companion Diagnostic Assay - Melanoma
  • NFE2L2 Companion Diagnostic Assay - Lung Cancer
  • NKX3.1 Companion Diagnostic Assay - Prostate Cancer
  • NPM1 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • NRAS Companion Diagnostic Assay - Colorectal Cancer
  • NRAS Companion Diagnostic Assay - Lung Cancer
  • NRAS Companion Diagnostic Assay - Melanoma
  • NTRK1/2/3 Companion Diagnostic Assay - Colorectal Cancer
  • NTRK1/2/3 Companion Diagnostic Assay - Lung Cancer
  • NUP98 Companion Diagnostic Assay - Acute Myeloid Leukemia
  • NUP98/RAP1GDS1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • P53 Companion Diagnostic Assay - Brain Cancer
  • p53 Companion Diagnostic Assay - Sarcoma
  • PD-1/PD-L1 Companion Diagnostic Assay - Breast Cancer
  • PD-L1 Companion Diagnostic Assay - Lung Cancer
  • PD-L2 Companion Diagnostic Assay - Lung Cancer
  • PDGFRA Companion Diagnostic Assay - Gastric Cancer
  • PDGFRA Companion Diagnostic Assay - Glioblastoma
  • PDGFRB Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • PDGFRB Companion Diagnostic Assay - Melanoma
  • PDGFRB Companion Diagnostic Assay - Myelodysplastic Syndrome
  • Periostin Based Companion Diagnostic Assay - Asthma
  • PICALM Companion Diagnostic Assay - Alzheimer’s Disease
  • PIK3CA Companion Diagnostic Assay - Bladder Cancer
  • PIK3CA Companion Diagnostic Assay - Brain Cancer
  • PIK3CA Companion Diagnostic Assay - Breast Cancer
  • PIK3CA Companion Diagnostic Assay - Colorectal Cancer
  • PIK3CA Companion Diagnostic Assay - Kidney Cancer
  • PIK3CA Companion Diagnostic Assay - Lung Cancer
  • PIK3CA Companion Diagnostic Assay - Ovarian Cancer
  • PIK3R1 Companion Diagnostic Assay - Glioblastoma
  • PLEX-ID - Orthopedic Infection Rapid Assay
  • PML/RARA Companion Diagnostic Assay - Myelodysplastic Syndrome
  • Point-Of-Care Test - Hepatitis C Virus RNA Detection
  • PRAME Antigen Lung Cancer Assay
  • PTEN Companion Diagnostic Assay - Breast Cancer
  • PTEN Companion Diagnostic Assay - Colorectal Cancer
  • PTEN Companion Diagnostic Assay - Glioblastoma
  • PTEN Companion Diagnostic Assay - Lung Cancer
  • PTEN Companion Diagnostic Assay - Melanoma
  • PTEN Companion Diagnostic Assay - Ovarian Cancer
  • PTEN Companion Diagnostic Assay - Prostate Cancer
  • PTEN Companion Diagnostic Assay - Renal Cancer
  • RET Companion Diagnostic Assay - Lung Cancer
  • ROS1 Companion Diagnostic Assay - Lung Cancer
  • RPN11/MECOM inv(3) or t(3;3) Companion Diagnostic Assay - Acute Myeloid Leukemia
  • RREB1 Companion Diagnostic Assay - Melanoma
  • SARS-CoV-2 IgG II Quant Test
  • Serology Test - Zika Virus
  • SMAD4 Companion Diagnostic Assay - Colorectal Cancer
  • t(15;17) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • t(17p) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • t(2;8) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • t(3;v) Companion Diagnostic Assay - Lymphoma
  • t(8;21) Companion Diagnostic Assay - Myelodysplastic Syndrome
  • t(8;22) Companion Diagnostic Assay - Acute Lymphocytic Leukemia
  • TAL1/STIL Companion Diagnostic Assay - Acute Lymphocytic Leukamia
  • TCR-B Companion Diagnostic Assay - Lymphoma
  • TERC Companion Diagnostic Assay - Cervical Cancer
  • TERT Companion Diagnostic Assay - Acute Myeloid Leukemia
  • TERT Companion Diagnostic Assay - Breast Cancer
  • TERT Companion Diagnostic Assay - Melanoma
  • TLX3/BCL11B Companion Diagnostic Assay - Acute Lymphocytic Leukamia
  • TOP2A Companion Diagnostic Assay - Breast Cancer
  • TP53 Companion Diagnostic Assay - Breast Cancer
  • TP53 Companion Diagnostic Assay - Leukemia
  • TP53 Companion Diagnostic Assay - Melanoma
  • TP53 Companion Diagnostic Assay - Multiple Myeloma
  • TP53/ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia
  • TSC1 Companion Diagnostic Assay - Bladder Cancer
  • Whole Blood Test - TBI
  • Zinc Assay
  • ZNF217 Companion Diagnostic Assay - Breast Cancer
  • Abbott Diagnostics - Key Competitors
  • Abbott Diagnostics - Key Employees
  • Abbott Diagnostics - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Abbott Diagnostics, Recent Developments
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
  • Abbott Diagnostics Pipeline Products by Equipment Type
  • Abbott Diagnostics Pipeline Products by Indication
  • Abbott Diagnostics Ongoing Clinical Trials by Trial Status
  • Abbott Diagnostics, Key Facts
  • Abbott Diagnostics, Major Products and Services
  • Abbott Diagnostics Number of Pipeline Products by Development Stage
  • Abbott Diagnostics Pipeline Products Summary by Development Stage
  • Abbott Diagnostics Ongoing Clinical Trials by Trial Status
  • Abbott Diagnostics Ongoing Clinical Trials Summary
  • 13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • 13q14.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Status
  • ACTN4 Companion Diagnostic Assay - Lung Cancer - Product Description
  • AKT Companion Diagnostic Assay - Breast Cancer - Product Status
  • AKT Companion Diagnostic Assay - Breast Cancer - Product Description
  • AKT Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • AKT Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • AKT Companion Diagnostic Assay - Renal Cancer - Product Status
  • AKT Companion Diagnostic Assay - Renal Cancer - Product Description
  • Alinity i AdviseDx SARS-CoV-2 IgM Assay - Product Status
  • Alinity i AdviseDx SARS-CoV-2 IgM Assay - Product Description
  • Alinity i Assay - TBI - Product Status
  • Alinity i Assay - TBI - Product Description
  • ALK Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • ALK Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • ALK Companion Diagnostic Assay - Lung Cancer - Product Status
  • ALK Companion Diagnostic Assay - Lung Cancer - Product Description
  • AR Companion Diagnostic Assay - Breast Cancer - Product Status
  • AR Companion Diagnostic Assay - Breast Cancer - Product Description
  • AR Companion Diagnostic Assay - Prostate Cancer - Product Status
  • AR Companion Diagnostic Assay - Prostate Cancer - Product Description
  • Architect AdviseDx SARS-Cov-2 IgM Assay - Product Status
  • Architect AdviseDx SARS-Cov-2 IgM Assay - Product Description
  • Architect Assay - TBI - Product Status
  • Architect Assay - TBI - Product Description
  • ARCHITECT c16000 System - Ca 72.2 Assay - Product Status
  • ARCHITECT c16000 System - Ca 72.2 Assay - Product Description
  • ARCHITECT c4000 System - Ca 72.2 Assay - Product Status
  • ARCHITECT c4000 System - Ca 72.2 Assay - Product Description
  • ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
  • ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
  • ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Status
  • ARCHITECT c4000 System - Kappa And Lamda Freelite Chains Assay - Product Description
  • ARCHITECT c4000 System - TRAb Assay - Product Status
  • ARCHITECT c4000 System - TRAb Assay - Product Description
  • ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status
  • ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description
  • ARCHITECT c8000 System - Ca 72.2 Assay - Product Status
  • ARCHITECT c8000 System - Ca 72.2 Assay - Product Description
  • ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
  • ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
  • ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin
  • ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Status
  • ARCHITECT c8000 System - Kappa And Lamda Freelite Chains Assay - Product Description
  • ARCHITECT c8000 System - TRAb Assay - Product Status
  • ARCHITECT c8000 System - TRAb Assay - Product Description
  • ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Status
  • ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Description
  • ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status
  • ARCHITECT ci16200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description
  • ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status
  • ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description
  • ARCHITECT ci16200 Integrated System - TRAb Assay - Product Status
  • ARCHITECT ci16200 Integrated System - TRAb Assay - Product Description
  • ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status
  • ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description
  • ARCHITECT ci4100 Integrated System - TRAb Assay - Product Status
  • ARCHITECT ci4100 Integrated System - TRAb Assay - Product Description
  • ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Status
  • ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Description
  • ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Status
  • ARCHITECT ci8200 Integrated System - Kappa And Lamda Freelite Chains Assay - Product Description
  • ARCHITECT ci8200 Integrated System - TRAb Assay - Product Status
  • ARCHITECT ci8200 Integrated System - TRAb Assay - Product Description
  • ARCHITECT i1000SR - NT Pro BNP Assay - Product Status
  • ARCHITECT i1000SR - NT Pro BNP Assay - Product Description
  • ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Status
  • ARCHITECT i2000SR Integrated System - NT Pro BNP Assay - Product Description
  • ATM 11q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • ATM 11q22.3 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • AURKA Companion Diagnostic Assay - Bladder Cancer - Product Status
  • AURKA Companion Diagnostic Assay - Bladder Cancer - Product Description
  • AURKA Companion Diagnostic Assay - Prostate Cancer - Product Status
  • AURKA Companion Diagnostic Assay - Prostate Cancer - Product Description
  • AXL Companion Diagnostic Assay - Lung Cancer - Product Status
  • AXL Companion Diagnostic Assay - Lung Cancer - Product Description
  • BCL2 Companion Diagnostic Assay - Leukemia - Product Status
  • BCL2 Companion Diagnostic Assay - Leukemia - Product Description
  • BCL2 Companion Diagnostic Assay - Lymphoma - Product Status
  • BCL2 Companion Diagnostic Assay - Lymphoma - Product Description
  • BCL6 Companion Diagnostic Assay - Lymphoma - Product Status
  • BCL6 Companion Diagnostic Assay - Lymphoma - Product Description
  • BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • BCR/ABL Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • BCR/ABL Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Status
  • Biomarker-Based Molecular Diagnostic Test - Prostate Cancer - Product Description
  • BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • BRAF Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • BRAF Companion Diagnostic Assay - Gastric Cancer - Product Status
  • BRAF Companion Diagnostic Assay - Gastric Cancer - Product Description
  • BRAF Companion Diagnostic Assay - Glioblastoma - Product Status
  • BRAF Companion Diagnostic Assay - Glioblastoma - Product Description
  • BRAF Companion Diagnostic Assay - Lung Cancer - Product Status
  • BRAF Companion Diagnostic Assay - Lung Cancer - Product Description
  • BRAF Companion Diagnostic Assay - Melanoma - Product Status
  • BRAF Companion Diagnostic Assay - Melanoma - Product Description
  • BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Status
  • BRAF Companion Diagnostic Assay - Ovarian Cancer - Product Description
  • BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Status
  • BRCA1 Companion Diagnostic Assay - Ovarian Cancer - Product Description
  • BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Status
  • BRCA2 Companion Diagnostic Assay - Ovarian Cancer - Product Description
  • c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • c-MYC 8q24 Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • CBFB Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • CCND1 Companion Diagnostic Assay - Breast Cancer - Product Status
  • CCND1 Companion Diagnostic Assay - Breast Cancer - Product Description
  • CCND1 Companion Diagnostic Assay - Lymphoma - Product Status
  • CCND1 Companion Diagnostic Assay - Lymphoma - Product Description
  • CCND1 Companion Diagnostic Assay - Melanoma - Product Status
  • CCND1 Companion Diagnostic Assay - Melanoma - Product Description
  • CDK6 Companion Diagnostic Assay - Leukemia - Product Status
  • CDK6 Companion Diagnostic Assay - Leukemia - Product Description
  • CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • CDKN2C Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • CEBPE Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • Chromosome 12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • Chromosome 17 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Status
  • Chromosome 3 Companion Diagnostic Assay - Cervical Cancer - Product Description
  • Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • Chromosome 4 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • Chromosome 7 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • Chromosome 7 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • Chromosome 8 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Status
  • Chromosome X Companion Diagnostic Assay - Cervical Cancer - Product Description
  • cKIT Companion Diagnostic Assay - Gastric Cancer - Product Status
  • cKIT Companion Diagnostic Assay - Gastric Cancer - Product Description
  • cKIT Companion Diagnostic Assay - Melanoma - Product Status
  • cKIT Companion Diagnostic Assay - Melanoma - Product Description
  • CKS1B Companion Diagnostic Assay - Breast Cancer - Product Status
  • CKS1B Companion Diagnostic Assay - Breast Cancer - Product Description
  • CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • CKS1B Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • CLL FISH Probe Kit - Ibrutinib - Product Status
  • CLL FISH Probe Kit - Ibrutinib - Product Description
  • cMET Companion Diagnostic Assay - Brain Cancer - Product Status
  • cMET Companion Diagnostic Assay - Brain Cancer - Product Description
  • cMET Companion Diagnostic Assay - Breast Cancer - Product Status
  • cMET Companion Diagnostic Assay - Breast Cancer - Product Description
  • cMET Companion Diagnostic Assay - Kidney Cancer - Product Status
  • cMET Companion Diagnostic Assay - Kidney Cancer - Product Description
  • cMET Companion Diagnostic Assay - Lung Cancer - Product Status
  • cMET Companion Diagnostic Assay - Lung Cancer - Product Description
  • Companion Diagnostic Test - B-cell Lymphoma - Product Status
  • Companion Diagnostic Test - B-cell Lymphoma - Product Description
  • Companion Diagnostic Test - Cancer - Product Status
  • Companion Diagnostic Test - Cancer - Product Description
  • COT Companion Diagnostic Assay - Melanoma - Product Status
  • COT Companion Diagnostic Assay - Melanoma - Product Description
  • CRAF Companion Diagnostic Assay - Melanoma - Product Status
  • CRAF Companion Diagnostic Assay - Melanoma - Product Description
  • CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Status
  • D5S23 Companion Diagnostic Assay - Cervical Cancer - Product Description
  • D5S23/D5S721 CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • D5S23/D5S721 CEP 9 Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • D5S721 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • D5S721 Companion Diagnostic Assay - Cervical Cancer - Product Status
  • D5S721 Companion Diagnostic Assay - Cervical Cancer - Product Description
  • D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • D7S486 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • D7S486 Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • D7S552 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • DCC Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • DCC Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • DDR2 Companion Diagnostic Assay - Lung Cancer - Product Status
  • DDR2 Companion Diagnostic Assay - Lung Cancer - Product Description
  • DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
  • DEK/NUP214 Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
  • del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • del(13q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • del(17p) Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • del(17p) Companion Diagnostic Assay - Multiple Myeloma - Product Status
  • del(17p) Companion Diagnostic Assay - Multiple Myeloma - Product Description
  • del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • del(5q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • del(7q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Status
  • del(9q) Companion Diagnostic Assay - Myelodysplastic Syndrome - Product Description
  • DOT1L Companion Diagnostic Test - Product Status
  • DOT1L Companion Diagnostic Test - Product Description
  • DPP4 Based Companion Diagnostic Assay - Asthma - Product Status
  • DPP4 Based Companion Diagnostic Assay - Asthma - Product Description
  • E2A/PBX1 (TCF/PBX1) Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • E2A/PBX1 (TCF/PBX1) Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
List of Figures
  • Abbott Diagnostics Pipeline Products by Equipment Type
  • Abbott Diagnostics Pipeline Products by Development Stage
  • Abbott Diagnostics Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Banyan Biomarkers Inc
  • Bio-Rad Laboratories Inc
  • Cellgen Diagnostics
  • Diamond Diagnostics
  • Nova Biomedical Corp

Related Topics

Copyright © 2002-2024 Research and Markets. All Rights Reserved.